Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AGEN · against 352 other Healthcare companies of similar size
Ranked #35 of 353 · scores higher than 89% of peers
Bars: peers in each 10-point band of the valuation score44 peers with a valuation score of 90–100, including AGEN · Click a bar to see the companies
Mainly thanks to its earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | AGEN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 337 reported | 37.9% | -0.4% | 99% | 30% | |
| EBITDA yieldHigher is better · 358 reported | 12.9% | 1.8% | 85% | 50% | |
| Free cash flow yieldHigher is better · 182 reported | -32.7% | -9.2% | 17% | 20% | |
| Book yieldHigher is better · 345 reported | -70.0% | 51.4% | 2% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 30 | 37.6B JPY (≈$256M) | 93 | 58 | |
| 30 | 261M USD | 93 | 97 | |
| 35 | 1.6B HKD (≈$209M) | 92 | 54 | |
| 35 | 1.1B MYR (≈$245M) | 92 | 70 | |
| 35 | 301M USD | 92 | 67 | |
| 35 | 251M EUR (≈$276M) | 92 | 52 | |
| 35 | 2.91T IDR (≈$180M) | 92 | 50 | |
| 35 | 298M CHF (≈$342M) | 92 | 74 | |
| 41 | 585.5B KRW (≈$422M) | 91 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score